Skip to main content
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1982 Nov;45(11):1048–1052. doi: 10.1136/jnnp.45.11.1048

Genetic and immunologic analysis on moya-moya.

T Kitahara, K Okumura, A Semba, A Yamaura, H Makino
PMCID: PMC491644  PMID: 6983566

Abstract

The genetic and immunologic abnormalities associated with the pathogenesis of moya-moya were assessed in 23, 13 children and 10 adults with angiographically diagnosed moya-moya. In HLA-A, -B, -C stereotyping, an association was found of AW24, BW46, and BW54 with relative risks of 3.83, 6.50, and 3.58 respectively. Natural T cell toxic autoantibody was detected by FACS analysis in sera from five out of 23 patients. Millipore filter assay for autoantibody against double-stranded DNA revealed higher than normal binding in sera from four out of 18 patients. Anti-vessel antibody which might be responsible for vascular change associated with moya-moya was not detected in any of the 23 patients studied. Significant association of the disease with certain HLA types, in addition to the presence of natural T cell toxic autoantibody and anti-double-stranded DNA antibody in patients' sera, supports the theory that genetic and immunologic disturbances may underly the pathogenesis of moya-moya.

Full text

PDF
1049

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aotsuka S., Okawa M., Ikebe K., Yokohari R. Measurement of anti-double-stranded DNA antibodies in major immunoglobulin classes. J Immunol Methods. 1979;28(1-2):149–162. doi: 10.1016/0022-1759(79)90337-5. [DOI] [PubMed] [Google Scholar]
  2. Herzenberg L. A., Sweet R. G., Herzenberg L. A. Fluorescence-activated cell sorting. Sci Am. 1976 Mar;234(3):108–117. doi: 10.1038/scientificamerican0376-108. [DOI] [PubMed] [Google Scholar]
  3. Kitahara T., Ariga N., Yamaura A., Makino H., Maki Y. Familial occurrence of moya-moya disease: report of three Japanese families. J Neurol Neurosurg Psychiatry. 1979 Mar;42(3):208–214. doi: 10.1136/jnnp.42.3.208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Knapp W., Pateisky K. Lymphocytotoxins in myasthenia gravis. Z Immunitatsforsch Exp Klin Immunol. 1972 Dec;144(4):329–334. [PubMed] [Google Scholar]
  5. Ooi B. S., Orlina A. R., Pesce A. J., Mendoza N., Masaitis L., Pollak V. E. Lymphocytotoxic antibodies in patients with systemic lupus erythematosus. Clin Exp Immunol. 1974 Jun;17(2):237–243. [PMC free article] [PubMed] [Google Scholar]
  6. Shirai T., Hayakawa K., Okumura K., Tada T. Differential cytotoxic effect of natural thymocytotoxic autoantibody of NZB mice on functional subsets of T cells. J Immunol. 1978 Jun;120(6):1924–1929. [PubMed] [Google Scholar]
  7. Shirai T., Mellors R. C. Natural thymocytotoxic autoantibody and reactive antigen in New Zealand black and other mice. Proc Natl Acad Sci U S A. 1971 Jul;68(7):1412–1415. doi: 10.1073/pnas.68.7.1412. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Thomas D. B. Antibodies to membrane antigen(s) common to thymocytes and a subpopulation of lymphocytes in infectious-mononucleosis sera. Lancet. 1972 Feb 19;1(7747):399–403. doi: 10.1016/s0140-6736(72)90854-9. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES